Patents by Inventor Martin Sos

Martin Sos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and Compositions For Identifying And Treating Patients With Small Cell Lung Cancer
    Publication number: 20220073998
    Abstract: Described herein are methods and compositions useful in detecting, diagnosing and treating small cell lung cancer. Transgenic animal models and cell lines are disclosed for the study of a small cell lung cancer subtype. Methods of screening and identifying active agents for the treatment of a small cell lung cancer subtype as well as methods of identifying patients susceptible to treatment with aurora kinase inhibitors are also provided.
    Type: Application
    Filed: September 20, 2021
    Publication date: March 10, 2022
    Inventors: Trudy Oliver, Martin Sos, Rob Wechsler-Reya
  • Methods and compositions for identifying and treating patients with small cell lung cancer
    Patent number: 11124841
    Abstract: Described herein are methods and compositions useful in detecting, diagnosing and treating small cell lung cancer. Transgenic animal models and cell lines are disclosed for the study of a small cell lung cancer subtype. Methods of screening and identifying active agents for the treatment of a small cell lung cancer subtype as well as methods of identifying patients susceptible to treatment with aurora kinase inhibitors are also provided.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: September 21, 2021
    Assignee: University Of Utah Research Foundation
    Inventors: Trudy Oliver, Martin Sos, Rob Wechsler-Reya
  • METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING PATIENTS WITH SMALL CELL LUNG CANCER
    Publication number: 20200010901
    Abstract: Described herein are methods and compositions useful in detecting, diagnosing and treating small cell lung cancer. Transgenic animal models and cell lines are disclosed for the study of a small cell lung cancer subtype. Methods of screening and identifying active agents for the treatment of a small cell lung cancer subtype as well as methods of identifying patients susceptible to treatment with aurora kinase inhibitors are also provided.
    Type: Application
    Filed: October 27, 2017
    Publication date: January 9, 2020
    Inventors: Trudy Oliver, Martin Sos, Rob Wechsler-Reya
  • Substituted pyrazolo[3,4-D]pyrimidines and uses thereof
    Patent number: 9895373
    Abstract: Presented herein are novel therapeutic compounds and methods of using the same for the treatment of cancers.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: February 20, 2018
    Assignees: The Regents of the University of California, Icahn School of Medicine at Mount Sinai
    Inventors: Arvin C. Dar, Tirtha K. Das, Martin Sos, Trever G. Bivona, Kevan M. Shokat, Ross L. Cagan
  • SUBSTITUTED PYRAZOLO[3,4-D]PYRIMIDINES AND USES THEREOF
    Publication number: 20160354377
    Abstract: Presented herein are novel therapeutic compounds and methods of using the same for the treatment of cancers.
    Type: Application
    Filed: March 23, 2016
    Publication date: December 8, 2016
    Inventors: Arvin C. Dar, Tirtha K. Das, Martin Sos, Trever G. Bivona, Kevan M. Shokat, Ross L. Cagan
  • Substituted pyrazolo[3,4-D]pyrimidines and uses thereof
    Patent number: 9321772
    Abstract: Presented herein are novel therapeutic compounds and methods of using the same for the treatment of cancers.
    Type: Grant
    Filed: February 25, 2014
    Date of Patent: April 26, 2016
    Assignees: The Regents of the University of California, Icahn School of Medicine at Mount Sinai
    Inventors: Arvin C. Dar, Tirtha K. Das, Martin Sos, Trever G. Bivona, Kevan M. Shokat, Ross L. Cagan
  • SUBSTITUTED PYRAZOLO[3,4-D]PYRIMIDINES AND USES THEREOF
    Publication number: 20140243357
    Abstract: Presented herein are novel therapeutic compounds and methods of using the same for the treatment of cancers.
    Type: Application
    Filed: February 25, 2014
    Publication date: August 28, 2014
    Applicants: Mount Sinai School of Medicine, The Regents of the University of California
    Inventors: Arvin C. Dar, Tirtha K. Das, Martin Sos, Trever G. Bivona, Kevan M. Shokat, Ross L. Cagan